Advertisement
Surgery
Advanced searchSave search
Parathyroid| Volume 173, ISSUE 1, P117-123, January 2023

Download started.

Ok

C11 choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails

Published:October 10, 2022DOI:https://doi.org/10.1016/j.surg.2022.08.024
C11 choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails
Previous ArticleDiscussion
Next ArticleDiscussion

      Abstract

      Background

      Focused parathyroidectomy in primary hyperparathyroidism is possible with accurate preoperative localization. A growing body of data exists regarding the role of radio-labeled C11 choline positron emission tomography/computed tomography. In cases of nonlocalized disease, it may be a useful adjunct to ultrasound, (123)I/(99)Tc-sestamibi (I-123 sestamibi), or 4-dimensional computed tomography imaging.

      Methods

      Patients who received a neck and chest limited coverage C11 choline positron emission tomography/computed tomography for evaluation of primary hyperparathyroidism from 2017 to 2021 at a single institution were retrospectively reviewed. We assessed the sensitivity, positive predictive value, and false negative rate. We also compared these rates to the standard modalities of ultrasound, I-123 sestamibi, 4-dimensional computed tomography, and examined concordance rates.

      Results

      We identified 43 patients, of whom 33 had a positive C11 choline positron emission tomography/computed tomography finding. This cohort of patients had failed to localize on multiple standard imaging modalities. Twenty-five patients proceeded to surgery, 72% of whom were reoperative cases. Twenty (80%) achieved an intraoperative cure. Analysis showed that C11 choline positron emission tomography/computed tomography achieved a sensitivity of 64% (95% confidence interval 47%–82%) and positive predictive value of 72% (95% confidence interval 54%–90%). There were 5/25 (20%) false positive positron emission tomography C11 choline results found to be lymph nodes, normal parathyroid, and 1 recurrent laryngeal nerve neuroma.

      Conclusion

      C
      • Parvinian A.
      • Martin-Macintosh E.L.
      • Goenka A.H.
      • et al.
      11C-Choline PET/CT for detection and localization of parathyroid adenomas.
      AJR Am J Roentgenol. 2018; 210: 418-422
      choline positron emission tomography/computed tomography is a useful adjunct for parathyroid localization in a complex population of patients who have failed standard localization techniques including ultrasound, I-123 sestamibi, or 4-dimensional computed tomography and/or prior operations. Although routine inclusion of C11 choline positron emission tomography/computed tomography imaging may not be necessary, it may aid in preoperative localization in the reoperative setting.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee G.S.
        • McKenzie T.J.
        • Mullan B.P.
        • Farley D.R.
        • Thompson G.B.
        • Richards M.L.
        A multimodal imaging protocol, (123)I/(99)Tc-sestamibi, SPECT, and SPECT/CT, in primary hyperparathyroidism adds limited benefit for preoperative localization.
        World J Surg. 2016; 40: 589-594
        View in Article
        • Yeh R.
        • Tay Y.-K.D.
        • Tabacco G.
        • et al.
        Diagnostic performance of 4D CT and sestamibi SPECT/CT in localizing parathyroid adenomas in primary hyperparathyroidism.
        Radiology. 2019; 291: 469-476
        View in Article
        • Thompson G.B.
        • Mullan B.P.
        • Grant C.S.
        • et al.
        Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience.
        Surgery. 1994; 116 (discussion 972–973): 966-972
        View in Article
        • Zander D.
        • Bunch P.M.
        • Policeni B.
        • et al.
        ACR Appropriateness Criteria parathyroid adenoma.
        J Am Coll Radiol. 2021; 18: S406-422
        View in Article
        • Petranović Ovčariček P.
        • Giovanella L.
        • Carrió Gasset I.
        • et al.
        The EANM practice guidelines for parathyroid imaging.
        Eur J Nucl Med Mol Imaging. 2021; 48: 2801-2822
        View in Article
        • Prommegger R.
        • Wimmer G.
        • Profanter C.
        • et al.
        Virtual neck exploration: a new method for localizing abnormal parathyroid glands.
        Ann Surg. 2009; 250: 761-765
        View in Article
        • Wei W.-J.
        • Shen C.-T.
        • Song H.-J.
        • Qiu Z.-L.
        • Luo Q.-Y.
        Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: a meta-analysis.
        Hell J Nucl Med. 2015; 18: 127-135
        View in Article
        • Leung K.
        [11C]Choline.
        in: Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, Bethesda, MD2004
        http://www.ncbi.nlm.nih.gov/books/NBK23549/
        Date accessed: February 14, 2022
        View in Article
      9. FDA. Highlights of prescribing information.
        https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203155s000lbl.pdf
        Date accessed: February 14, 2022
        View in Article
        • Welle C.L.
        • Cullen E.L.
        • Peller P.J.
        • et al.
        11C-Choline PET/CT in recurrent prostate cancer and nonprostatic neoplastic processes.
        RadioGraphics. 2016; 36: 279-292
        View in Article
        • Parvinian A.
        • Martin-Macintosh E.L.
        • Goenka A.H.
        • et al.
        11C-Choline PET/CT for detection and localization of parathyroid adenomas.
        AJR Am J Roentgenol. 2018; 210: 418-422
        View in Article
        • Orevi M.
        • Freedman N.
        • Mishani E.
        • Bocher M.
        • Jacobson O.
        • Krausz Y.
        Localization of parathyroid adenoma by 11C-choline PET/CT: preliminary results.
        Clin Nucl Med. 2014; 39: 1033-1038
        View in Article
        • Dy B.M.
        • Richards M.L.
        • Vazquez B.J.
        • Thompson G.B.
        • Farley D.R.
        • Grant C.S.
        Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not?.
        Ann Surg Oncol. 2012; 19: 2272-2278
        View in Article
        • Christensen J.W.
        • Jensen L.T.
        • Søndergaard S.B.
        • et al.
        Locating hyperfunctioning parathyroid glands using 11C-choline PET/CT: an inter- and intra-observer variation study.
        Eur J Hybrid Imaging. 2021; 5: 13
        View in Article
        • Oksüz M.O.
        • Dittmann H.
        • Wicke C.
        • et al.
        Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.
        Diagn Interv Radiol. 2011; 17: 297-307
        View in Article
        • Piccardo A.
        • Trimboli P.
        • Rutigliani M.
        • et al.
        Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile.
        Eur J Nucl Med Mol Imaging. 2019; 46: 766-775
        View in Article
        • Broos W.A.M.
        • van der Zant F.M.
        • Knol R.J.J.
        • Wondergem M.
        Choline PET/CT in parathyroid imaging: a systematic review.
        Nucl Med Commun. 2019; 40: 96-105
        View in Article
        • Kluijfhout W.P.
        • Pasternak J.D.
        • Drake F.T.
        • et al.
        Use of PET tracers for parathyroid localization: a systematic review and meta-analysis.
        Langenbecks Arch Surg. 2016; 401: 925-935
        View in Article
        • Lee S.-W.
        • Shim S.R.
        • Jeong S.Y.
        • Kim S.-J.
        Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism: a systematic review and network meta-analysis.
        JAMA Otolaryngol Head Neck Surg. 2021; 147: 692-706
        View in Article
        • Hope T.A.
        • Graves C.E.
        • Calais J.
        • et al.
        Accuracy of 18F-fluorocholine PET for the detection of parathyroid adenomas: prospective single-center study.
        J Nucl Med. 2021; 62: 1511-1516
        View in Article
        • Imaging Technology News
        Illinois hospital offering C-11 choline PET imaging for prostate cancer.
        http://www.itnonline.com/content/illinois-hospital-offering-c-11-choline-pet-imaging-prostate-cancer
        Date accessed: February 14, 2022
        View in Article
        • Englewood Health
        Choline C-11 PET now offered at Englewood Hospital and Medical Center.
        https://www.englewoodhealth.org/choline-c-11-pet-now-offered-englewood-hospital-medical-center
        Date accessed: February 14, 2022
        View in Article
        • Wang T.S.
        • Cheung K.
        • Farrokhyar F.
        • Roman S.A.
        • Sosa J.A.
        Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.
        Surgery. 2011; 150: 1286-1294
        View in Article

      Article info

      Publication history

      Published online: October 10, 2022
      Accepted: August 9, 2022

      Identification

      DOI: https://doi.org/10.1016/j.surg.2022.08.024

      Copyright

      © 2022 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX